Literature DB >> 23190290

Chronic Lyme; diagnostic and therapeutic challenges.

U Ljøstad1, Å Mygland.   

Abstract

In this review, we aim to discuss the definition, clinical and laboratory features, diagnostics, and management of chronic Lyme. Chronic Lyme is a rare condition caused by long-lasting and ongoing infection with the spirochete Borrelia burgdorferi (Bb). The most common manifestations are progressive encephalitis, myelitis, acrodermatitis chronica atrophicans with or without neuropathy, and arthritis. Chronic Lyme is not considered to present with isolated subjective symptoms. Direct detection of Bb has low yield in most manifestations of chronic Lyme, while almost 100% of the cases are seropositive, that is, have detectable Bb IgG antibodies in serum. Detection of Bb antibodies only with Western blot technique and not with ELISA and detection of Bb IgM antibodies without simultaneous detection of Bb IgG antibodies should be considered as seronegativity in patients with long-lasting symptoms. Patients with chronic Lyme in the nervous system (neuroborreliosis) have, with few exceptions, pleocytosis and production of Bb antibodies in their cerebrospinal fluid. Strict guidelines should be applied in diagnostics of chronic Lyme, and several differential diagnoses, including neurological disease, rheumatologic disease, post-Lyme disease syndrome, chronic fatigue syndrome, and psychiatric disease, should be considered in the diagnostic workup. Antibiotic treatment with administration route and dosages according to current guidelines are recommended. Combination antimicrobial therapy or antibiotic courses longer than 4 weeks are not recommended. Patients who attribute their symptoms to chronic Lyme on doubtful basis should be offered a thorough and systematic diagnostic approach, and an open and respectful dialogue.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23190290     DOI: 10.1111/ane.12048

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  9 in total

1.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

2.  Asymmetric red-bluish foot due to acrodermatitis chronica atrophicans.

Authors:  Anh Ly Nguyen; Wim J A de Kort; Chantal C W Theunissen
Journal:  BMJ Case Rep       Date:  2016-06-22

3.  Non-viable Borrelia burgdorferi induce inflammatory mediators and apoptosis in human oligodendrocytes.

Authors:  Geetha Parthasarathy; Helene B Fevrier; Mario T Philipp
Journal:  Neurosci Lett       Date:  2013-10-22       Impact factor: 3.046

4.  Virome analysis of Amblyomma americanum, Dermacentor variabilis, and Ixodes scapularis ticks reveals novel highly divergent vertebrate and invertebrate viruses.

Authors:  Rafal Tokarz; Simon Hedley Williams; Stephen Sameroff; Maria Sanchez Leon; Komal Jain; W Ian Lipkin
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

Review 5.  Lyme disease: call for a "Manhattan Project" to combat the epidemic.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

Review 6.  Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review.

Authors:  Liesbeth Borgermans; Geert Goderis; Jan Vandevoorde; Dirk Devroey
Journal:  Int J Family Med       Date:  2014-11-24

7.  Personalized medicine: evidence of normativity in its quantitative definition of health.

Authors:  Henrik Vogt; Bjørn Hofmann; Linn Getz
Journal:  Theor Med Bioeth       Date:  2016-10

8.  The Diagnostic Challenges and Clinical and Serological Outcome in Patients Hospitalized for Suspected Lyme Neuroborreliosis.

Authors:  Violeta Briciu; Mirela Flonta; Daniel Leucuța; Mihaela Lupșe
Journal:  Microorganisms       Date:  2022-07-11

9.  Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Front Cell Infect Microbiol       Date:  2013-08-14       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.